Skip to content

Clinical trials

Enrolling by invitation Phase 3 trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 3 Status: Enrolling by invitation Country / region: Australia Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20192
20201
20211
20224
20233
20241
20255

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Enrolling by invitation18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
United Therapeutics2
AstraZeneca1
BioMarin Pharmaceutical1
Celldex Therapeutics1
Cybin IRL Limited1
Eli Lilly and Company1
Grifols Therapeutics LLC1
Ionis Pharmaceuticals, Inc.1
Longboard Pharmaceuticals1
Pharvaris Netherlands B.V.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsy2
Seizures2
Amyloidosis1
Angioedemas, Hereditary1
Cardiovascular Diseases1
Chronic Urticaria1
Connective Tissue Diseases1
Cystic Fibrosis1
Dermatitis, Atopic1
Eczema1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.